Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11958849
GLS1 inhibitors for treating disease
granted -
US 11952330
Antibiotic ammonium compounds and methods for the treatment of bacterial infections
granted -
US 11951118
Preparation of preliposomal annamycin lyophilizate
granted -
US 11946065
Transgene cassettes, AAV vectors, and AAV viral vectors for expression of human codon-optimized CSTB
granted -
US 11939370
Pan-ebola virus neutralizing human antibodies and methods of use therefor
granted -
US 11925654
Esters of 2-deoxy-monosaccharides with anti proliferative activity
granted -
US 11926824
miRNA biogenesis in exosomes for diagnosis and therapy
granted -
US 11925642
Regulation of eIF4E activity for migraine therapy
granted -
US 11918646
Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
granted -
US 11919927
Prefusion-stabilized hMPV F proteins
granted -
US 11919937
T cell receptors for immunotherapy
granted -
US 11912762
Method of treating osteoarthritis by administering an anti-connexin 43 antibody
granted -
US 11913883
Highly specific tissue imaging
granted -
US 11912758
Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannel
granted -
US 11906519
Methods for identifying LILRB-blocking antibodies
granted -
US 11903936
Anti-malarial agents
granted -
US 11905297
OX2R compounds
granted -
US 11896558
Use of an RXR agonist and taxanes in treating Her2+ cancers
granted -
US 11890320
CLEC11A is a bone growth agent
granted -
US 11890344
One-step processing of hydrogels for mechanically robust and chemically desired features
granted -
US 11891616
Transgene cassettes designed to express a human MECP2 gene
granted -
US 11885861
3-dimensional representations of post-contrast enhanced brain lesions
granted -
US 11883423
Nucleobase analogue derivatives and their applications
granted -
US 11878961
Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer
granted